KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Cash & Current Investments (2016 - 2025)

Rigel Pharmaceuticals has reported Cash & Current Investments over the past 16 years, most recently at $155.0 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 100.4% year-over-year to $155.0 million; the TTM value through Dec 2025 reached $155.0 million, up 100.4%, while the annual FY2025 figure was $155.0 million, 100.4% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $155.0 million at Rigel Pharmaceuticals, up from $137.1 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $155.0 million in Q4 2025 and troughed at $39.3 million in Q1 2021.
  • A 5-year average of $87.7 million and a median of $77.2 million in 2024 define the central range for Cash & Current Investments.
  • Biggest five-year swings in Cash & Current Investments: tumbled 58.98% in 2021 and later surged 173.27% in 2022.
  • Year by year, Cash & Current Investments stood at $125.0 million in 2021, then tumbled by 53.42% to $58.2 million in 2022, then decreased by 2.19% to $56.9 million in 2023, then skyrocketed by 35.81% to $77.3 million in 2024, then soared by 100.4% to $155.0 million in 2025.
  • Business Quant data shows Cash & Current Investments for RIGL at $155.0 million in Q4 2025, $137.1 million in Q3 2025, and $108.4 million in Q2 2025.